BloodThinnerHelp.com reports today on one of the more notable cases filed in the Xarelto multidistrict litigation. A lawsuit against the manufacturers of Xarelto was originally filed in the Eastern District of New York and later moved to the Xarelto MDL in the Eastern District of Louisiana, by a Texas woman alleging that Xarelto’s manufacturer’s failure to warn and perform adequate safety testing on the drug led to her serious, long term injuries. Many of the other lawsuits filed in the MDL make similar allegations. The complaint is filed under federal court docket number 1:14-CV-04524 and can be downloaded and read here.
Allegations Made Against Xarelto’s Manufacturers:
In this particular case, the plaintiff began to take Xarelto after it was prescribed by her doctor to treat a heart condition she suffered from called atrial fibrillation and to prevent blood clots that could result from that condition. The plaintiff, age 73 at the time, was taking the blood thinner for five months when she suffered a serious, life threatening internal bleeding event. The internal bleed left her with serious injury. The complaint filed did not specifically state the exact injuries she suffered, but it did specify that the injuries are permanent and will require long term future care. The lawsuit filed alleges that Xarelto was the proximate cause of her internal bleed, that the manufacturers of Xarelto failed to adequately warn patients and doctors about the true dangers of the drug, and that the manufacturers were negligent in releasing the drug onto the market without also releasing a corresponding antidote.
The Dangers of Xarelto
Lawsuits allege that Xarelto is a much more dangerous drug than other blood thinners on the market because it does not come with a corresponding antidote, meaning that there is no drug available to reverse the anticoagulant effects of Xarelto. This is dangerous because if a patient taking Xarelto suffers from an internal bleed, such as the plaintiff in this case, there is no way short of extreme lifesaving measure to stop the bleed and very often these leave the patient with serious injuries. The FDA has issued several warnings regarding the safety of Xarelto, including two black box warnings. The black box warnings are the strictest warnings the FDA can attach to a drug short of recalling it. It means that there is a reasonable risk of hazard associated with the drug. The FDA warnings regarding Xarelto can be found here.
For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.
###
Contact BloodThinnerHelp.com:
Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.
